To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RPLP0P9TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
87 supporting clones for gene RPLP0P9 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AI566612 adenocarcinoma, Pancreas .a-u 1 to 195 194 to 1       194/223
(86 %)
16 diff
(92.9 %id)
EL953220 eyeball .a-u 3 to 376 10 to 383 S41L tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 374/383
(97 %)
7 diff
(98.2 %id)
BF893681.
matches multiple genes
marrow .a-u 5 to 272 283 to 12     Submitted on the opposite strand, also hits gene RPLP0P6 272/284
(95 %)
0 diff
(100 %id)
AV738617 cord Blood .a-u 5 to 374 18 to 374 L2W L13C L14C H15I Q16S ... AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 357/376
(94 %)
12 diff
(96.9 %id)
EC554881 Prostate .a-u 5 to 101 1 to 97       97/97
(100 %)
5 diff
(94.9 %id)
AI934226 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a-u 5 to 378 377 to 1 V4G S5L V6S C7A R8D ...     377/382
(98 %)
7 diff
(98.2 %id)
BF058173 fibrotheoma, ovary .a-u 5 to 386 384 to 1 L2F R8K S41L K114E     384/390
(98 %)
10 diff
(97.5 %id)
CX782582 human embryonic stem cells .a-u 5 to 376 413 to 42 T23R S41L S48F AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 372/568
(65 %)
9 diff
(98.5 %id)
TI_43964164   .a-u 5 to 304 301 to 1   tiling clone,   301/778
(38 %)
5 diff
(99.4 %id)
TI_154092753   .a-u 5 to 376 456 to 85 S41L AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 372/1091
(34 %)
6 diff
(99.5 %id)
TI_157613033   .a-u 5 to 376 472 to 101 S21* AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 372/728
(51 %)
7 diff
(99.1 %id)
EL950414 eyeball .a-u 9 to 208 1 to 201       201/201
(100 %)
5 diff
(97.6 %id)
BM312281 Pancreas, Purified pancreatic islet .a-u 10 to 376 1 to 367 S41L AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 367/367
(100 %)
5 diff
(98.7 %id)
BX356651 Placenta Cot 25-normalized .a-u 11 to 376 11 to 376 S41L tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 366/376
(97 %)
6 diff
(98.5 %id)
EC542539 Prostate .a-u 11 to 106 1 to 94       94/94
(100 %)
5 diff
(94.7 %id)
AA513440 breast .a-u 13 to 391 379 to 1 L2F P3Q S5P C7*     379/410
(92 %)
11 diff
(97.4 %id)
AA935967 metastatic prostate bone lesion .a-u 13 to 376 385 to 17 L2C V4W S5A C7L R8K ... AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 369/404
(91 %)
25 diff
(93.9 %id)
AV752904 Pituitary .a-u 13 to 376 1 to 364 S41L AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 364/364
(100 %)
2 diff
(99.5 %id)
CN396371 embryonic stem cells, DMSO-treated H9 cellline .a-u 14 to 376 1 to 363 S41L AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 363/363
(100 %)
2 diff
(99.5 %id)
BX450251 placenta .a-u 15 to 376 1 to 362 S41L AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 362/362
(100 %)
2 diff
(99.5 %id)
EC499217 Prostate .a-u 15 to 111 1 to 97       97/97
(100 %)
0 diff
(100 %id)
AA071561   .a-u 16 to 377 364 to 1 L2X P3X V4S S5V V6C ...     364/407
(89 %)
9 diff
(97.8 %id)
BQ710555 Spleen .a-u 16 to 376 1 to 361 S41L AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 361/361
(100 %)
2 diff
(99.5 %id)
AA888294.
matches multiple genes
metastatic prostate bone lesion .a-u 23 to 376 8 to 358     also hits gene RPLP0P6 351/358
(98 %)
6 diff
(98.4 %id)
BQ029692 lung, Metastatic Chondrosarcoma .a-u 26 to 376 370 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 352/352
(100 %)
6 diff
(98.3 %id)
BF314210 brain, neuroblastoma .a-u 28 to 376 1 to 349   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 349/349
(100 %)
4 diff
(98.9 %id)
BX429353 brain, fetal brain .a-u 29 to 376 1 to 348   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 348/348
(100 %)
2 diff
(99.5 %id)
EC528072 Prostate .a-u 32 to 130 1 to 99       99/99
(100 %)
0 diff
(100 %id)
BM836289 stomach .a-u 32 to 376 1 to 345   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 345/345
(100 %)
2 diff
(99.5 %id)
EC439961 Prostate .a-u 33 to 104 72 to 1       72/72
(100 %)
0 diff
(100 %id)
EC543043 Prostate .a-u 33 to 99 77 to 11       67/77
(87 %)
0 diff
(100 %id)
BX450697 brain, fetal brain .a-u 38 to 376 1 to 338   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 338/338
(100 %)
3 diff
(99.2 %id)
CN396336 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 44 to 376 1 to 333   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 333/333
(100 %)
2 diff
(99.4 %id)
AA482995 Ewing's sarcoma .a-u 47 to 384 341 to 6       336/341
(98 %)
0 diff
(100 %id)
AA737102 Ewing's sarcoma .a-u 47 to 376 1 to 327   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 327/327
(100 %)
11 diff
(96.7 %id)
BX368153 Neuroblastoma Cot 25-normalized .a-u 51 to 376 1 to 326   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 326/326
(100 %)
3 diff
(99.1 %id)
AW246710 lung, small cell carcinoma .a-u 54 to 386 333 to 1       333/333
(100 %)
2 diff
(99.4 %id)
BQ232016 melanotic melanoma, skin .a-u 67 to 376 1 to 310   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 310/310
(100 %)
2 diff
(99.4 %id)
BG055174 Prostate .a-u 69 to 384 316 to 1       316/316
(100 %)
6 diff
(98.2 %id)
BM829686 stomach .a-u 72 to 376 1 to 304   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 304/304
(100 %)
15 diff
(95.1 %id)
AI611330 Prostate .a-u 75 to 391 319 to 1       319/319
(100 %)
9 diff
(97.2 %id)
CB140985 Liver .a-u 79 to 376 1 to 298   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 298/298
(100 %)
2 diff
(99.4 %id)
BM747277 Ascites, stomach .a-u 79 to 376 1 to 298   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 298/298
(100 %)
2 diff
(99.4 %id)
AV737103 cord Blood .a-u 83 to 376 45 to 338   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 294/338
(86 %)
6 diff
(98.3 %id)
BI758908.
matches multiple genes
pooled colon, kidney, stomach .a-u 83 to 376 14 to 309   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base), also hits gene RPLP0P6 296/309
(95 %)
6 diff
(98.1 %id)
BF752810 breast_normal .a-u 85 to 376 1 to 290   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 290/290
(100 %)
7 diff
(97.6 %id)
BF763480 colon_est .a-u 85 to 384 1 to 300       300/300
(100 %)
2 diff
(99.4 %id)
CN396304 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 85 to 376 1 to 292   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 292/292
(100 %)
5 diff
(98.3 %id)
BI757697 brain .a-u 87 to 376 1 to 289   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 289/289
(100 %)
3 diff
(99.0 %id)
CN396356 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 91 to 376 1 to 286   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 286/286
(100 %)
2 diff
(99.4 %id)
BF752221 breast_normal .a-u 93 to 376 29 to 310   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 282/310
(90 %)
6 diff
(98.1 %id)
BM988627 lung, Metastatic Chondrosarcoma .a-u 94 to 376 301 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 283/285
(99 %)
3 diff
(99.0 %id)
AV682124 hepatocellular carcinoma .a-u 97 to 376 1 to 280   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 280/280
(100 %)
2 diff
(99.3 %id)
BI010765 lung_normal .a-u 104 to 269 1 to 166       166/166
(100 %)
8 diff
(95.2 %id)
AA522477 metastatic prostate bone lesion .a-u 105 to 387 282 to 1       282/288
(97 %)
8 diff
(97.3 %id)
AA659217 metastatic prostate bone lesion .a-u 105 to 393 296 to 7       290/302
(96 %)
0 diff
(100 %id)
BG181051 adenocarcinoma, cell line, Prostate .a-u 106 to 376 1 to 270   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 270/270
(100 %)
3 diff
(98.9 %id)
BG251037 adenocarcinoma, cell line, Liver .a-u 107 to 376 1 to 270   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 270/270
(100 %)
2 diff
(99.3 %id)
TI_151709450   .a-u 110 to 376 350 to 84   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 267/267
(100 %)
11 diff
(95.9 %id)
BM820765 Ascites, stomach .a-u 112 to 376 1 to 265   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 265/265
(100 %)
2 diff
(99.3 %id)
BM742598 Ascites, stomach .a-u 112 to 376 1 to 265   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 265/265
(100 %)
2 diff
(99.3 %id)
BX429739 neuroblastoma .a-u 115 to 378 1 to 260       260/268
(97 %)
8 diff
(97.1 %id)
AA887110 metastatic prostate bone lesion .a-u 115 to 376 1 to 260   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 260/260
(100 %)
10 diff
(96.2 %id)
D54332   .a-u 134 to 376 46 to 288       243/288
(84 %)
6 diff
(98.0 %id)
BU735876 eye, fetal eyes .a-u 140 to 392 263 to 4       260/263
(98 %)
0 diff
(100 %id)
AA369417 placenta .a-u 142 to 376 235 to 1       235/236
(99 %)
2 diff
(99.2 %id)
AW001301 colon, colonic mucosa from 3 patients with Crohn'sdisease .a-u 143 to 366 224 to 1       224/224
(100 %)
4 diff
(98.3 %id)
BP385562 pancreatic islet .a-u 144 to 383 1 to 240     Submitted on the opposite strand 240/240
(100 %)
1 diff
(99.6 %id)
AA176299   .a-u 148 to 377 229 to 1       229/234
(97 %)
7 diff
(97.1 %id)
TI_1948075986   .a-u 148 to 313 289 to 124       166/189
(87 %)
0 diff
(100 %id)
EC450822 Prostate .a-u 153 to 231 1 to 79       79/79
(100 %)
0 diff
(100 %id)
EC523932 Prostate .a-u 155 to 234 1 to 79       79/79
(100 %)
1 diff
(98.8 %id)
EC539024 Prostate .a-u 155 to 234 1 to 80       80/80
(100 %)
0 diff
(100 %id)
CX784620 human embryonic stem cells .a-u 160 to 376 1 to 216   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 216/216
(100 %)
2 diff
(99.1 %id)
BM990887 lung, Lung Focal Fibrosis .a-u 163 to 376 232 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 214/221
(96 %)
1 diff
(99.6 %id)
TI_1948075426.
matches multiple genes
  .a-u 163 to 313 273 to 123     also hits gene RPLP0P6 151/174
(86 %)
0 diff
(100 %id)
CB109711 Liver .a-u 164 to 376 1 to 213   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 213/213
(100 %)
2 diff
(99.1 %id)
AA226148   .a-u 167 to 385 226 to 1       226/229
(98 %)
10 diff
(95.7 %id)
BU564199 mixed (pool of 40 RNAs) .a-u 170 to 400 1 to 231       231/242
(95 %)
10 diff
(95.9 %id)
TI_1948075711   .a-u 180 to 313 256 to 123       134/157
(85 %)
0 diff
(100 %id)
AA551696 normal prostatic epithelial cells, Prostate .a-u 183 to 393 1 to 211       211/216
(97 %)
13 diff
(94.0 %id)
F28000 pectoral muscle (after mastectomy) .a-u 191 to 267 1 to 77       77/77
(100 %)
0 diff
(100 %id)
AA434231 ovarian tumor, ovary .a-u 195 to 389 195 to 1       195/195
(100 %)
4 diff
(98.0 %id)
BM786113 stomach .a-u 195 to 376 1 to 182   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 182/182
(100 %)
1 diff
(99.5 %id)
AA583698 Kidney, kidney tumor .a-u 220 to 376 183 to 24   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 160/192
(83 %)
9 diff
(95.4 %id)
BX326210 Neuroblastoma Cot 25-normalized .a-u 235 to 385 1 to 150       150/150
(100 %)
6 diff
(96.0 %id)
EC571161 Prostate .a-u 254 to 376 127 to 2       126/127
(99 %)
0 diff
(100 %id)
? Gene Summary Gene on genome mRNA Expression Tissue Function, regulation, related genes